Fields of Application
- EU Guidelines to Good Manufacturing Practice for medicinal products, Annex 1: Manufacture of sterile medicinal products; March 2009
- FDA Guidance for Industry: Sterile drug products produced by aseptic processing - current good manufacturing practice, U.S. Department of Health and Human Services; Food and Drug Administration; September 2004.
Instructions for use
Prepare the working solution by filling water of an appropriate quality into a tub or bucket. Add the concentrate to the water and stir gently.
For example:
1 bottle (60 ml) for 4 L = 1,5 % solution.
Wipe the surfaces until they are well wetted and observe required contact time.
Product data
Composition:
100 g solution contains the following active substances: 10 g Didecyldimethylammonium chloride, 2 g N-(3-aminopropyl)-N-dodecylpropane-1,3-diamine.
Labelling according to Regulation (EC) No. 648/2004: < 5 % non-ionic surfactants.
Other ingredients: <= 5 g Propan-2-ol, < 5 g Tridecylpolyethylenglycolether.
Chemical-physical data
Special advice
Use disinfectants safely. Always read the label and product information before use.
Information for order
Item | Delivery form | Item | GTIN |
---|---|---|---|
perform® sterile concentrate Q2 5x60 ml bottle | 4 / carton(s) | 70003024 | 4032651983537 |
perform® sterile concentrate Q2 CN 5x60 ml bottle | 4 / carton(s) | 70002278 | 4032651977567 |